Dr Jaime Bayona of Socios en Salud
Jaime Bayona, MD, MPH is the Founding Director of Socios En Salud Sucursal Peru (SES), a Lima-based organization that has had significant impact on policies for prevention and treatment of drug-resistant tuberculosis (TB) and HIV and provided training and technical assistance around the world.
A leader in international health and social medicine, Dr Bayona is an authority on programmatic approaches to the control of multidrug-resistant TB and a long-time advocate for community-based primary care. He is the author of numerous publications related to TB control and treatment methods and is currently a co-investigator in a multi-institutional grant funded by the US National Institutes of Health to study the epidemiology of multidrug-resistant TB in Lima.
Dr Bayona received his MD in 1986 from The School of Medicine, National University of Trujillo in Peru and his MPH in 1992 from the Joint Center for Public Health Studies, College of Medicine, University of Wales, UK
Professor Emeritus Denis Mitchison
Denis Mitchison, CMG, MB, FRCP, FRCPath., has had a distinguished career in tuberculosis research, beginning with his pioneering studies on anti-tuberculosis chemotherapy more than half a century ago. The author of 245 scientific papers, he is the recipient of many awards, including the Weber-Parkes Prize Medal, Royal College of Physicians (1978), the Philip Medal, Chest & Heart Association (1981), the Medal of Honour, International Union against Tuberculosis & Lung Disease (1987) the Presidential Award, American Thoracic Society (1989), the Severi Savonen Medal, Finnish Lung Health Association, (1999) and the British Thoracic Society Medal (2000).
A graduate of Trinity College at Cambridge and University College Hospital Medical School he completed postgraduate studies in pathology before beginning studies on streptomycin at Brompton Hospital in 1947 as one of three people on the original bacteriological committee. In 1956 he was appointed director of the Medical Research Council Unit for Research on Drug Sensitivity in Tuberculosis at the Royal Postgraduate Medical School in Hammersmith (now Imperial College). In that role he was responsible for the design of groundbreaking randomized trials in Madras, India comparing inpatient and outpatient treatment of TB - the first major studies of home care.
In 1985 Dr Mitchison retired from his position but not from science. He continued his work at Hammersmith for four years before moving to Saint George’s, University of London, where he has continued an active career in tuberculosis research.